Open Access
| Issue |
E3S Web Conf.
Volume 319, 2021
International Congress on Health Vigilance (VIGISAN 2021)
|
|
|---|---|---|
| Article Number | 01025 | |
| Number of page(s) | 5 | |
| DOI | https://doi.org/10.1051/e3sconf/202131901025 | |
| Published online | 09 November 2021 | |
- Protocole de prise en charge des patients des patients atteints de Covid-19 et leurs contacts. Circulaire n°23/DELM/2020 du 24 Mars 2020 mise à jour le 14 avril [Google Scholar]
- Le sulfate de Chloroquine (Nivaquine®) et le Sulfate d’Hydroxychloroquine (Plaquénil®) dans le protocole thérapeutique de l’infection par le virus SARS-CoV-2 Recommandations du Centre Antipoison et de Pharmacovigilance du Maroc CAPM. http://www.covidmaroc.ma/Documents/2020/coronavirus/PS/Note_CAPM_CQHCQ_Mai-compresse%CC%81.pdf [Google Scholar]
- COVID-19 – Chronologie de l’action de l’OMS. https://www.who.int/fr/news/item/27-04-2020-who-timeline---covid-19. Accessed juin, 14 2021 [Google Scholar]
- Moore N. Chloroquine for COVID-19 Infection. Drug Safety 2020;43:393-394; https://doi.org/10.1007/s40264-020-00933-4 [Google Scholar]
- Cortegiani A, Ippolito M, Ingoglia G, Iozzo P, Giarratano A, Einav S. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19, Journal of Critical Care 2020;59:176-190; https://doi.org/10.1016/j.jcrc.2020.06.019. [Google Scholar]
- Food and Drug Administration. Review of Hydroxychloroquine and Chloroquine. 2020; https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/OSE%20Review_Hydroxychloroqui e-Cholorquine%20 %2019May2020_Redacted.pdf. accessed 22 December 2020. [Google Scholar]
- Chloroquine et hydroxychloroquine dans la prise en charge du COVID-19. https://www.elsevier.com/frfr/connect/medecine/chloroquine-et-hydroxychloroquine-dans-la-prise-en-charge-du-covid-19. [Google Scholar]
- COVID-19: PREMIÈRES DONNÉES DE PHARMACOVIGILANCE POUR L’HYDROXYCHLOROQUINE ET LOPINAVIR/RITONAVIR. Par DAVID PAITRAUD - date de publication: 14 avril 2020. https://www.vidal.fr/actualites/24741-covid-19-premieres-donnees-de-pharmacovigilance-pour-l-hydroxychloroquine-et-lopinavir ritonavir.html [Google Scholar]
- Bulletin épidémiologique COVID 19 édité par le Centre National des Opérations d’Urgences de Santé Publique/Direction de l’Épidémiologie ET EDE Lutte CONTRE LES Maladies. Numéro 8 du 30/06/2020. https://www.sante.gov.ma/Publications/Bullten_pidmiologique/3-COVID-19%20%20Bulletin%20%C3%A9pid%C3%A9miologique%20(30-06-2020).pdf [Google Scholar]
- World Health Organisation. Descriptive analysis of COVID-19-related spontaneous reports from VigiBase: interim results. 2020;. https://www.who.int/medicines/regulation/medicines-safety/COVID19-PVupdate6. pdf?ua=1. Accessed 30 July 2020. Accessed 14 juin 2021. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.